Literature DB >> 18336339

Relationship between drugs and functional activity of various mammalian P-glycoproteins (ABCB1).

In-Wha Kim1, Catherine Booth-Genthe, Suresh V Ambudkar.   

Abstract

P-glycoprotein (Pgp, ABCB1) is an efflux transporter for a variety of amphipathic agents that can affect the pharmacokinetics of drugs. In order to extrapolate transport and pharmacokinetic data of the drug candidates obtained from in vitro and animal models to those in humans, it is important to understand the functional differences of Pgps from various mammalian species including human, monkey, dog, rat, and mouse. Here, we review differences/similarities in the properties of Pgp from numerous mammalian species commonly used in preclinical studies and discuss their relevance to the pharmacokinetics of potential drug molecules.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18336339     DOI: 10.2174/138955708783744100

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  12 in total

1.  Human ABCC1 interacts and colocalizes with ATP synthase α, revealed by interactive proteomics analysis.

Authors:  Youyun Yang; Zhaomin Li; Wei Mo; Raghuram Ambadipudi; Randy J Arnold; Petra Hrncirova; Milos V Novotny; Elias Georges; Jian-Ting Zhang
Journal:  J Proteome Res       Date:  2012-01-18       Impact factor: 4.466

2.  Role of transmembrane segment 5 and extracellular loop 3 in the homodimerization of human ABCC1.

Authors:  Youyun Yang; Wei Mo; Jian-Ting Zhang
Journal:  Biochemistry       Date:  2010-12-02       Impact factor: 3.162

3.  Synthesis and structure-activity evaluation of isatin-β-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein.

Authors:  Matthew D Hall; Kyle R Brimacombe; Matthew S Varonka; Kristen M Pluchino; Julie K Monda; Jiayang Li; Martin J Walsh; Matthew B Boxer; Timothy H Warren; Henry M Fales; Michael M Gottesman
Journal:  J Med Chem       Date:  2011-08-01       Impact factor: 7.446

Review 4.  Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.

Authors:  Deepali Waghray; Qinghai Zhang
Journal:  J Med Chem       Date:  2017-12-28       Impact factor: 7.446

Review 5.  Use of in vivo animal models to assess pharmacokinetic drug-drug interactions.

Authors:  Cuyue Tang; Thomayant Prueksaritanont
Journal:  Pharm Res       Date:  2010-04-29       Impact factor: 4.200

6.  The antiepileptic drug topiramate is a substrate for human P-glycoprotein but not multidrug resistance proteins.

Authors:  Carlos Luna-Tortós; Bernhard Rambeck; Uwe H Jürgens; Wolfgang Löscher
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

7.  Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1).

Authors:  Kristen M Pluchino; Matthew D Hall; Janna K Moen; Eduardo E Chufan; Patricia A Fetsch; Suneet Shukla; Deborah R Gill; Stephen C Hyde; Di Xia; Suresh V Ambudkar; Michael M Gottesman
Journal:  Biochemistry       Date:  2016-02-10       Impact factor: 3.162

8.  Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans.

Authors:  Mi Sun Jin; Michael L Oldham; Qiuju Zhang; Jue Chen
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

Review 9.  Drug interactions at the blood-brain barrier: fact or fantasy?

Authors:  Sara Eyal; Peng Hsiao; Jashvant D Unadkat
Journal:  Pharmacol Ther       Date:  2009-04-22       Impact factor: 13.400

10.  Identification of a Cryptic Bacterial Promoter in Mouse (mdr1a) P-Glycoprotein cDNA.

Authors:  Kristen M Pluchino; Dominic Esposito; Janna K Moen; Matthew D Hall; James P Madigan; Suneet Shukla; Lauren V Procter; Vanessa E Wall; Thomas D Schneider; Ian Pringle; Suresh V Ambudkar; Deborah R Gill; Steven C Hyde; Michael M Gottesman
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.